Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T82051 | ||||
Target Name | mRNA of TP53 | ||||
Synonyms | Antigen NYCO13 (mRNA); Cellular tumor antigen p53 (mRNA); Phosphoprotein p53 (mRNA); TP53 (mRNA); Tumor suppressor p53 (mRNA); TP53 | ||||
Target Type | Clinical Trial | ||||
Gene Name | TP53 | ||||
Biochemical Class | Target of siRNA drug | ||||
UniProt ID | P53_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Acute myelocytic leukemia | ||||
Example drug | Cenersen | Phase 2 | [1], [2], [3] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.30 Z-score: 0.59 P-value: 7.90E-07 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
![]() |
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
![]() |
|||||
Reference | |||||
REF 1 | Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer. 2012 Jan 15;118(2):418-27. | ||||
REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8270). | ||||
REF 3 | NCBI GEO: archive for functional genomics data sets--update. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.